Carregant...
CAR T-cell Therapy for Pancreatic Cancer
Chimeric antigen receptor (CAR) T-cell therapy utilizes genetic engineering to redirect a patient’s own T cells to target cancer cells. The remarkable results in hematological malignancies prompted investigating this approach in solid tumors such as pancreatic cancer. The complex tumor microenvironm...
Guardat en:
| Publicat a: | J Surg Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5491361/ https://ncbi.nlm.nih.gov/pubmed/28346697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.24627 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|